WH Brady & Company Intrinsic Value
WH Brady & Company (WHBRADY) median intrinsic value is ₹247.57 from 3 valuation models (range ₹235–₹290), vs current price ₹520.00 — -52.4% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit WH Brady & Company screener.
WHBRADY Valuation Methods Summary — DCF, Graham Number & P/E
WH Brady & Company intrinsic value across 3 models vs current price ₹520.00 — upside/downside and value range per method. Analyse WHBRADY shareholding pattern to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹290.00 | ₹261.00 - ₹319.00 | -44.2% | Book Value/Share: ₹290.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹234.67 | ₹211.20 - ₹258.14 | -54.9% | Revenue/Share: ₹293.33, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹247.57 | ₹198.06 - ₹297.08 | -52.4% | CF Growth: 5.0%, Discount: 15% |
WHBRADY Intrinsic Value vs Market Price — All Valuation Models
WH Brady & Company fair value range ₹235–₹290 vs current market price ₹520.00 across 3 valuation models. Read WHBRADY ex-dividend dates for the complete payout history and dividend yield track record.
WHBRADY Intrinsic Value Analysis — Undervalued or Overvalued?
WH Brady & Company median intrinsic value ₹247.57, current price ₹520.00 — Trading Above Calculated Value by 52.4%, margin of safety -100.0%.
What is the intrinsic value of WHBRADY?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of WH Brady & Company (WHBRADY) is ₹247.57 (median value). With the current market price of ₹520.00, this represents a -52.4% variance from our estimated fair value.
The valuation range spans from ₹234.67 to ₹290.00, indicating ₹234.67 - ₹290.00.
Is WHBRADY undervalued or overvalued?
Based on our multi-method analysis, WH Brady & Company (WHBRADY) appears to be trading above calculated value by approximately 52.4%.
WHBRADY Financial Health — Key Ratios vs Industry Benchmarks
WH Brady & Company financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.20 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.68x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
WHBRADY Cash Flow Quality — Operating & Free Cash Flow
WH Brady & Company operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹8 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹11 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹5 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹11 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |